KeeneyRLRaiffaH. Decisions with Multiple Objectives: Preferences and Value Tradeoffs. Hoboken, NJ: John Wiley; 1976.
2.
PrattJW. Risk aversion in the small and in the large. Econometrica. 1964;32:122–36.
3.
RossSA. Some stronger measures of risk aversion in the small and in the large. Econometrica. 1981;49:621–38.
4.
MachinaMJNeilsonWS. The Ross characterization of risk aversion: strengthening and extension. Econometrica. 1987;55:1139–49.
5.
JindaponPNeilsonWS. Higher-order generalizations of Arrow-Pratt and Ross risk aversion: a comparative statistics approach. J Econ Theory. 2007;136:719–28.
6.
KimballMS. Standard risk aversion. Econometrica. 1993;61:589–611.
7.
RogerP. Risk apportionment: a story of moments. Sept2007; Strasbourg University, LARGE Research Center. Available from: URL: http://ssrn.com/abstract=1021491
8.
KimballMS. Precautionary saving in the small and in the large. Econometrica. 1990;58:53–73.
9.
KimballMS. Precautionary motives for holding assets. National Bureau of Economic Research Working Paper #3586. 1991. Also in: NewmanPMilgateMFalwellJ, eds. The New Palgrave Dictionary of Money and Finance. London: MacMillan; 1992.
10.
EeckhoudtLSchlesingerH. Putting risk in its proper place. Am Econ Rev. 2006;96:280–9.
11.
FelderSMayrhoferT. Risk preferences: consequences for test and treatment thresholds and optimal cutoffs. Med Decis Making. 2014;34(1):33–41.
12.
KriegerMMayrhoferT. Patient preferences and treatment thresholds under diagnostic risk. Ruhr Economic Papers #321;2012.
13.
BleichrodtHCrainichDEeckhoudtL. The effect of comorbidites on treatment decisions. J Health Econ. 2003;22:805–29.
14.
EeckhoudtLGollierCSchlesingerH. Changes in background risk and risk taking behavior. Econometrica. 1966;64:683–99.
15.
Lajerri-ChaherliF: Proper prudence, standard prudence and precautionary vulnerability. Econ Lett. 2004;82:29–34.
16.
PliskinJSShepardDSWeinsteinMC. Utility functions for life years and health status. Oper Res. 1980;28:206–24.
17.
GollierCPrattJW. Risk vulnerability and the tempering effect of background risk. Econometrica. 1996;64:1109–23.
18.
EeckhoudtLReyB. Risk vulnerability: a graphical interpretation. Theory and Decision. 2011;71:227–34.
19.
DeckCSchlesingerH. Exploring higher order risk effects. Rev Econ Stud. 2010;77:1403–20.
20.
PaukerSGKassirerJP. Therapeutic decision making: a cost-benefit analysis. N Engl J Med. 1975;293:229–34.
21.
PaukerSGKassirerJP. The threshold approach to clinical decision making. N Engl J Med. 1980;302:1109–17.
22.
FelderSMayrhoferT. Higher-order risk preferences: consequences for test and treatment thresholds and optimal cutoffs. Ruhr Economic Papers #287; 2011.
23.
EeckhoudtLLebrunTSaillyJC. Risk-aversion and physicians medical decision-making. J Health Econ. 1985;4:273–81.
24.
DjulbegovicBHozoIBecksteadJTsalatsanisAPaukerSG. Dual processing model of medical decision-making. BMC Med Inform Decis Mak. 2012;12:94. Available from: URL: http://www.biomedcentral.com/1472-6947/12/94